Shareholder newsletter has been released, very upbeat in terms of trial progress and good to see 2 patients have entered into the extenstion trial. Very personal feel to the newsletter, haven't quite seen something like this from many companies before.
Must read for all holders!
Add to My Watchlist
What is My Watchlist?